Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
26 studies found for:    " July 14, 2010":" August 13, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" July 14, 2010":" August 13, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+
Condition: HIV Seropositivity
Interventions: Other: ARV's + Placebo;   Drug: Naltrexone;   Drug: Naltrexone + ARV's
2 Unknown  Pilot Study of Raltegravir Lipodystrophy IISP
Condition: HIV Infection
Intervention: Drug: Raltegravir
3 Completed Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor
Condition: HIV Infection
Interventions: Drug: Lopinavir and ritonavir;   Drug: Triple therapy with ritonavir
4 Completed Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women
Condition: HIV Infections
Intervention: Procedure: surgical management of high grade lesions
5 Completed Feasibility and Limitations of Offering Community Based Rapid HIV Testing to Men Who Have Sex With Men (MSM)
Condition: HIV Infections
Interventions: Biological: blood test: rapid finger-stick blood specimen test;   Biological: blood test: conventional test
6 Completed Reducing HIV in Adolescents
Condition: HIV Infections
Interventions: Behavioral: Cash incentives;   Behavioral: Life skills curriculum
7 Unknown  Chronic HIV Infection and Aging in NeuroAIDS (CHAIN)
Conditions: HIV;   Aging
Intervention: Other: Observational
8 Withdrawn A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells
Conditions: HIV Infections;   Acquired Immune Deficiency Syndrome
Interventions: Drug: Raltegravir plus Truvada;   Drug: Atripla
9 Completed Impact of Nutrition Intervention on HIV/AIDS Infected Patients
Conditions: Human Immunodeficiency Virus (HIV);   Acquired Immune Deficiency Syndrome (AIDS)
Interventions: Dietary Supplement: Theragran-M; Ensure Plus;   Dietary Supplement: Theragran-M
10 Completed Linkage and Retention: A Randomized Trial to Optimize HIV/TB Care in South Africa
Condition: HIV
Intervention: Behavioral: Health System Navigator
11 Completed Russian Labor Migrant HIV Prevention Trial
Condition: HIV
Intervention: Behavioral: Social Network Intervention
12 Completed
Has Results
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
Condition: HIV
Intervention: Drug: Lopinavir/ritonavir
13 Completed A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 Infected Adults on ART
Condition: HIV-1 Infection
Intervention: Biological: JS7 plasmid DNA and MVA62B vaccine
14 Completed Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population
Condition: Human Immunodeficiency Virus
Interventions: Drug: tenofovir/emtricitabine/efavirenz (TDF/FTC/EFV);   Drug: tenofovir/emtricitabine (TDF/FTC);   Drug: Atazanavir (ATV);   Drug: Ritonavir;   Procedure: Phlebotomy
15 Active, not recruiting Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial
Condition: HIV-1
Intervention: Genetic: OZ1 transduced cells
16 Completed Impact of Raltegravir on HIV-1 cDNA Slope Following Antiretroviral Therapy (ART) Initiation
Condition: HIV-1
Intervention:
17 Terminated
Has Results
Open Label Study to Evaluate Chronic Hepatitis C Treatment in Latino Subjects With and Without HIV Co-infection
Conditions: Hepatitis C;   HIV
Intervention:
18 Completed PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial
Condition: HIV-1
Interventions: Drug: Efavirenz or Nevirapine;   Drug: Ritonavir-boosted lopinavir
19 Completed Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine 1437173A;   Biological: Placebo
20 Unknown  HIV Indicator Diseases Survey Across Europe - UK Arm
Conditions: HIV;   AIDS;   Indicator Diseases/Indicator Conditions
Interventions: Other: HIV test (serological or salivary);   Other: Interview

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.